EMMA EMMAUS LIFE SCIENCES INC NEW
- 0.100000
- 0.0000000.00%
EMMAUS LIFE SCIENCES INC NEW News
Great Elm Group And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed higher by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders inte
EMMAUS LIFE SCIENCES INC NEW(EMMA.US) Officer Buys US$14,694 in Common Stocks
$EMMAUS LIFE SCIENCES INC NEW(EMMA.US)$ Officer LEE WILLIS C purchased 115.2K shares of Common Stocks on Feb 26, 27, 28, 29, 2024 at an average price of $0.13 for a total value of $14,694.Source: Anno
Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico
TORRANCE, Calif., Feb. 2, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a leader in sickle cell disease (SCD) treatment, today announced that it has received marketing authorization f
(SEC Amendment) EMMAUS LIFE SCIENCES INC NEW(EMMA.US) Officer Buys US$15,285 in Common Stocks
$EMMAUS LIFE SCIENCES INC NEW(EMMA.US)$ Officer LEE WILLIS C purchased 121K shares of Common Stocks on Aug 25, 31, Nov 14, 28, 29, 30, 2023 at an average price of $0.13 for a total value of $15,285.So
EMMAUS LIFE SCIENCES INC NEW(EMMA.US) Director Buys US$30,916 in Common Stocks
$EMMAUS LIFE SCIENCES INC NEW(EMMA.US)$ Director Lim Seah H. purchased 139.2K shares of Common Stocks on Oct 9, 2022 and Aug 25, 30, Sep 5, 2023 at an average price of $0.22 for a total value of $30,9
EMMAUS LIFE SCIENCES INC NEW(EMMA.US) Officer Buys US$2,022.93 in Common Stocks
$EMMAUS LIFE SCIENCES INC NEW(EMMA.US)$ Officer LEE WILLIS C purchased 15,609 shares of Common Stocks on Aug 25, 31, Nov 14, 28, 29, 30, 2023 at an average price of $0.13 for a total value of $2,022.9
Emmaus Life Sciences GAAP EPS of -$0.01, Revenue of $5M
Earnings Flash (EMMA) EMMAUS LIFE SCIENCES Posts Q3 Revenue $5M
09:33 AM EST, 11/14/2023 (MT Newswires) -- Earnings Flash (EMMA) EMMAUS LIFE SCIENCES Posts Q3 Revenue $5M
Emmaus Life Sciences Names Willis Lee, George Sekulich Interim Co-Presidents >EMMA
Emmaus Life Sciences Names Willis Lee, George Sekulich Interim Co-Presidents >EMMA
Emmaus Life Sciences: Yutaka Niihara Will No Longer Serve as Chairman, CEO >EMMA
Emmaus Life Sciences: Yutaka Niihara Will No Longer Serve as Chairman, CEO >EMMA
Emmaus Life Sciences GAAP EPS of -$0.03, Revenue of $10.8M
Emmaus Life Sciences GAAP EPS of -$0.07, Revenue of $6.8M Beats by $1.8M
Earnings Flash (EMMA) EMMAUS LIFE SCIENCES Posts Q1 Revenue $6.8M
09:31 AM EDT, 05/15/2023 (MT Newswires) -- Earnings Flash (EMMA) EMMAUS LIFE SCIENCES Posts Q1 Revenue $6.8M
Express News | Emmaus Life Sciences 1Q Loss/Shr 7c >EMMA
Express News | Emmaus Life Sciences 1Q Rev $6.75M >EMMA
Express News | Emmaus Life Sciences Had Cash and Cash Equivalents of $1.8M at March 31 >EMMA
Press Release: Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update
Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update PR Newswire TORRANCE, Calif., May 15, 2023 TORRANCE, Calif., May 15, 2023 /PRNewswire/ -- Emmaus Life Sciences, I
Emmaus Life Sciences GAAP EPS of -$0.21, Revenue of $18.39M
Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update
TORRANCE, Calif., March 31, 2023 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX:EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported its results of
Emmaus Life Sciences GAAP EPS of -$0.01, Revenue of $4.94M
Analysis
Price Target
No Data
